AzTrials
AzTrials

Mental HealthNCT06822777

RISE for Nurse Preceptors

A study testing RISE for Nurse Preceptors Program in people with Mental Health and Resilience, run by AdventHealth at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether RISE for Nurse Preceptors has a significant impact on nurse preceptors' burnout, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Mental Health, Resilience, Self-Compassion
What is being tested?
RISE for Nurse Preceptors Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
1 siteUnited States
Study dates
1 Mar 2025to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult ≥ 18 years old
  • Licensed as an RN
  • Employed by AdventHealth Rocky Mountain Region
  • Completion of the AdventHealth preceptor training
  • Has precepted ≥ 48 hours within the past calendar year in an AdventHealth hospital setting or outpatient emergency center
  • Able to speak, read, and understand English fluently
  • Able to provide informed consent
  • Willing and able to comply with all study procedures and requirements for the duration of the study.

Who cannot join

  • Has precepted < 48 hours within the past calendar year
  • Does not pass the brief risk assessment in the pre-intervention introduction meeting with the LMHC facilitator
  • Unwilling or unable to comply with all study procedures and requirements for the duration of the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • AdventHealth

    Orlando, Florida, 32804

Other trials in United States

About this study

Official title: A Randomized Controlled Trial of RISE for Nurse Preceptors

The purpose of this study is to determine whether RISE for Nurse Preceptors has a significant impact on nurse preceptors' burnout, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.

Being tested
RISE for Nurse Preceptors Program
Medical subject headings
Psychological Well-Being, Empowerment, Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RISE for Nurse Preceptors ProgramBehavioural

    Psychoeducational group program designed to impact resilience, insight, self-compassion, and empowerment

Study groups in NCT06822777
Study groupRoleWhat they receive
Intervention groupExperimentalIntervention group will attend the RISE for Nurse Preceptors program, which consists of nine 90-minute weekly psychoeducational group sessions facilitated by a licensed mental health counselor (LMHC)
Receives: Behavioral: RISE for Nurse Preceptors Program
Wait-list control groupActive comparatorControl group will attend the RISE for Nurse Preceptors program after the 6-month wait-list period
Receives: Behavioral: RISE for Nurse Preceptors Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Professional Quality of Life Scale

    30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

Secondary outcomes (12)
  1. Posttraumatic Growth Inventory

    21-item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  2. Brief Resilience Scale

    6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  3. Self-Reflection and Insight Scale

    20-item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  4. Self-Compassion Scale - Short Form

    12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  5. Psychological Empowerment Instrument

    12-item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  6. General Self-Efficacy Scale

    10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  7. Perceived Stress Scale

    10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  8. Moral Injury Outcomes Scale

    14-item questionnaire with the following response categories: 0=strongly agree, 1=disagree, 2=neither agree or disagree, 3=agree, 4=strongly agree

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  9. Brief COPE

    28-item questionnaire with a scale of 1-4, with 1 meaning I haven't been doing this at all; and 4 meaning I've been doing this a lot

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  10. Generalized Anxiety Disorder - 2 item scale

    2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  11. Patient Health Questionnaire - 2 item

    2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

  12. Preceptor Self-Assessment Tool

    40-item scale with the following response categories: 1 (lowest), 2 (low), 3 (average), 4 (high), 5 (highest).

    Measured: Baseline, endpoint, and 1-, 3-, and 6-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2025
  2. Study start1 Mar 2025
  3. Primary completion2 Feb 2026
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
124 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06822777
Sponsor's protocol ID
2251716
Status last verified
Oct 2026
First submitted
7 Feb 2025
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bailey AK, Sawyer AT, Robinson PS. A Psychoeducational Group Intervention for Nurses: Rationale, Theoretical Framework, and Development. J Am Psychiatr Nurses Assoc. 2023 May-Jun;29(3):232-240. doi: 10.1177/10783903211001116. Epub 2021 Jun 22.

    PubMed 34154451
  • Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.

    PubMed 16250744
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PubMed 6668417
  • Grant, A. M., Franklin, J., & Langford, P. (2002). The Self-Reflection and Insight Scale: A new measure of private self-consciousness. Social Behavior and Personality, 30(8), 821-836.

  • Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.

    PubMed 14583691
  • Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004.

    PubMed 17339617
  • L'Ecuyer K, Subramaniam DS, Reansing C, DuBois JC. Psychometric Testing of the Preceptor Self-Assessment Tool (PSAT)-40 for Nursing Preceptors. J Contin Educ Nurs. 2022 Nov;53(11):491-499. doi: 10.3928/00220124-20221006-06. Epub 2022 Nov 1.

    PubMed 36318709
  • Litz BT, Plouffe RA, Nazarov A, Murphy D, Phelps A, Coady A, Houle SA, Dell L, Frankfurt S, Zerach G, Levi-Belz Y; Moral Injury Outcome Scale Consortium. Defining and Assessing the Syndrome of Moral Injury: Initial Findings of the Moral Injury Outcome Scale Consortium. Front Psychiatry. 2022 Jul 5;13:923928. doi: 10.3389/fpsyt.2022.923928. eCollection 2022.

    PubMed 35873252
  • Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8.

    PubMed 21584907
  • Sawyer AT, Bailey AK, Green JF, Sun J, Robinson PS. Resilience, Insight, Self-Compassion, and Empowerment (RISE): A Randomized Controlled Trial of a Psychoeducational Group Program for Nurses. J Am Psychiatr Nurses Assoc. 2023 Jul-Aug;29(4):314-327. doi: 10.1177/10783903211033338. Epub 2021 Jul 23.

    PubMed 34293934
  • Sawyer AT, Tao H, Bailey AK. The Impact of a Psychoeducational Group Program on the Mental Well-Being of Unit-Based Nurse Leaders: A Randomized Controlled Trial. Int J Environ Res Public Health. 2023 Jun 2;20(11):6035. doi: 10.3390/ijerph20116035.

    PubMed 37297639
  • Sawyer AT, McManus K, Bailey AK. A mixed-methods pilot study of a psychoeducational group programme for nurse managers during the COVID-19 pandemic. J Nurs Manag. 2022 Nov;30(8):4126-4137. doi: 10.1111/jonm.13881. Epub 2022 Nov 13.

    PubMed 36326077
  • Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.

    PubMed 18696313
  • Spreitzer, G. M. (1995). Psychological empowerment in the workplace: Dimensions, measurement, and validation. Academy of Management Journal, 38(5), 1442-1465.

  • Stamm, B. H. (2009). Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL). http://www.proqol.org.

Questions about this trial

What is this clinical trial studying?

A study testing RISE for Nurse Preceptors Program in people with Mental Health and Resilience, run by AdventHealth at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Professional Quality of Life Scale (time frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06822777, which also lists 16 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in